Eosinophilic Esophagitis: Towards Improved Management

Sponsor
Oslo University Hospital
Study ID
NCT06991881
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - 17 Years
Healthy Volunteers
Not accepted

Interventions

  • Biobank sampling for new biomarkers — OTHER
    Using biopsies as the gold standard, the project aims towards validating non-invasive biomarkers as specified previously against biopsies.

Study Details

The current project aims to improve the care for children and adolescents with eosinophilic esophagitis in a collaborative effort involving pediatric units at Oslo Unversity Hospital and Helse Bergen, Norway. Existing and new non-invasive biomarkers will be explored systematically, aiming to reduce the number of endoscopies and time on restricted diet.

Key Dates

Start date
Oct 31, 2023
Status verified
May 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025

Study Design

Enrollment
80 participants (estimated)

Primary Outcome Measure

Active eosinophilic esophagitis (>15 eosinophils per high-power field) [ Time Frame: 12 months ]

Central Contacts

Related Studies